Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition

Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition

Submitted by admin on November 10, 2024 - 9:31pm
Source: 
Forbes
News Tags: 
PBMs
drug rebates
biosimilars
Headline: 
Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition
snippet: 

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S. patient out-of-pocket costs are too high.

Do Not Allow Advertisers to Use My Personal information